Groups | GSH mg/dl erythrocyte | MDA nmol/ml | TAC mmol/L |
---|---|---|---|
Group 1: control | |||
 Range | 75–101.5 | 2.2–4.1 | 2.1–3.2 |
 Mean ± S.D | 85.9 ± 7.52 | 3.027 ± 0.52 | 2.74 ± 0.35 |
Group 2: diabetic model | |||
 Range | 20–41 | 8.6–12.8 | 0.9–1.9 |
 Mean ± S.D | 26.53 ± 6.35a | 10.35 ± 1.39a | 1.39 ± 0.27a |
Group 3: diabetic model + 4PBA | |||
 Range | 72–94 | 3.8–8.6 | 2–2.6 |
 Mean ± S.D | 84.4 ± 6b | 6.18 ± 1.53a,b | 2.28 ± 0.22a,b |
Group 4: diabetic model + TUDCA | |||
 Range | 55–95 | 4.8–8.4 | 1.9–2.9 |
 Mean ± S.D | 72.8 ± 11.9a,b | 6.34 ± 1.11a,b | 2.119 ± 0.24a,b |
Group 5: diabetic model + TMAO | |||
 Range | 46–88 | 2.8–5.7 | 2–2.5 |
 Mean ± S.D | 58.26 ± 10.56a,b | 4.213 ± 0.89a,b | 2.229 ± 0.14a,b |